Trial Profile
Safety and efficacy of dabigatran etexilate for prevention of stroke
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- 18 Nov 2015 New trial record